Capital One National Association’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $973K | Sell |
7,838
-321
| -4% | -$39.8K | 0.07% | 228 |
|
|
2018
Q1 | $909K | Sell |
8,159
-332
| -4% | -$37K | 0.06% | 238 |
|
|
2017
Q4 | $1.02M | Sell |
8,491
-1,143
| -12% | -$137K | 0.07% | 230 |
|
|
2017
Q3 | $1.35M | Buy |
9,634
+2,664
| +38% | +$374K | 0.09% | 188 |
|
|
2017
Q2 | $848K | Buy |
6,970
+3,676
| +112% | +$447K | 0.06% | 252 |
|
|
2017
Q1 | $399K | Buy |
3,294
+175
| +6% | +$21.2K | 0.03% | 376 |
|
|
2016
Q4 | $381K | Buy |
3,119
+867
| +38% | +$106K | 0.03% | 381 |
|
|
2016
Q3 | $276K | Buy |
2,252
+158
| +8% | +$19.4K | 0.02% | 434 |
|
|
2016
Q2 | $245K | Sell |
2,094
-1,040
| -33% | -$122K | 0.02% | 453 |
|
|
2016
Q1 | $436K | Sell |
3,134
-180
| -5% | -$25K | 0.04% | 360 |
|
|
2015
Q4 | $633K | Sell |
3,314
-436
| -12% | -$83.3K | 0.05% | 296 |
|
|
2015
Q3 | $587K | Buy |
3,750
+93
| +3% | +$14.6K | 0.06% | 306 |
|
|
2015
Q2 | $661K | Sell |
3,657
-11,252
| -75% | -$2.03M | 0.06% | 301 |
|
|
2015
Q1 | $2.58M | Buy |
14,909
+1,276
| +9% | +$221K | 0.23% | 102 |
|
|
2014
Q4 | $2.52M | Buy |
13,633
+212
| +2% | +$39.2K | 0.24% | 109 |
|
|
2014
Q3 | $2.23M | Sell |
13,421
-556
| -4% | -$92.2K | 0.22% | 122 |
|
|
2014
Q2 | $2.18M | Buy |
13,977
+9
| +0.1% | +$1.41K | 0.2% | 130 |
|
|
2014
Q1 | $2.13M | Buy |
13,968
+385
| +3% | +$58.6K | 0.21% | 125 |
|
|
2013
Q4 | $1.81M | Sell |
13,583
-1,425
| -9% | -$189K | 0.17% | 158 |
|
|
2013
Q3 | $1.74M | Sell |
15,008
-309
| -2% | -$35.9K | 0.18% | 162 |
|
|
2013
Q2 | $1.41M | Buy |
+15,317
| New | +$1.41M | 0.15% | 171 |
|